Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
877.79
-31.53 (-3.47%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
99
100
Next >
LifeMD Shares Come Back to Life on GLP-1 Business Growth
March 19, 2024
LifeMD stock is surging as the company is riding the GLP-1 trend to double-digit revenue growth and projections for 67% earnings growth in 2024
Via
MarketBeat
Is Madrigal Pharmaceuticals Stock a Better Buy Than Eli Lilly and Novo Nordisk After Its Huge FDA Win?
March 19, 2024
Madrigal has one key advantage over its two huge potential future rivals.
Via
The Motley Fool
Exposures
Product Safety
Wall Street’s Favorite Growth Stocks? 7 Names That Could Make You Filthy Rich
March 18, 2024
Growth stocks should continue to rise as the S&P 500 hits new highs, with rate cuts on the horizon expected to continue fueling the rally.
Via
InvestorPlace
Topics
Stocks
Exposures
US Equities
10 Health Care Stocks Whale Activity In Today's Session
March 18, 2024
Via
Benzinga
Eli Lilly Just Had a Setback. Is Its Stock Still a Buy?
March 16, 2024
The drugmaker is caught up in an unexpected situation with regulators.
Via
The Motley Fool
Should Investors Worry About Eli Lilly's Latest Regulatory Setback?
March 14, 2024
There are good reasons to remain optimistic.
Via
The Motley Fool
2 No-Brainer Stocks I'd Add to the "Magnificent Seven"
March 13, 2024
They fit right in.
Via
The Motley Fool
US Prescriptions Race For Weight Loss Drugs - Eli Lilly's Zepbound Overtakes Novo Nordisk's Wegovy
March 18, 2024
Latest in weight-loss medication trends: Eli Lilly And Co's Zepbound (tirzepatide) surges past rival Novo Nordisk A/S's Wegovy (semaglutide) in new prescriptions, signaling a shift in the obesity...
Via
Benzinga
Forget Eli Lilly. Buy This Magnificent Biotech Stock Instead
March 18, 2024
This company's growth story is about to get moving with gusto.
Via
The Motley Fool
The $1 Trillion Question: Will LLY, TSMC or TSLA Be Wall Street’s Next Nvidia?
March 17, 2024
While it's challenging to surpass the trillion dollar market capitalization mark, a few potentials are contending for the title.
Via
InvestorPlace
3 Unstoppable Stocks You Can Buy Now Without Any Hesitation
March 17, 2024
There's no need for delays in buying these great stocks.
Via
The Motley Fool
Eli Lilly Taps Amazon to Deliver Its Weight Management Blockbuster. Is It Time to Buy the Pharma Stock?
March 17, 2024
Free two-day shipping for Prime members and a direct-to-consumer sales model could accelerate sales of Eli Lilly's Zepbound.
Via
The Motley Fool
The Trillion-Dollar Crystal Ball: 3 Companies Next in Line for the Market Milestone
March 16, 2024
These three companies have the potential to cross over and become the next trillion-dollar stocks—so watch out.
Via
InvestorPlace
Eli Lilly Partners With Amazon's Pharmacy Business: Here's Why Both Stocks Should Win From the Deal
March 16, 2024
The world's biggest drugmaker has joined forces with the world's biggest online pharmacy provider.
Via
The Motley Fool
Here's How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 20 Years
March 15, 2024
Via
Benzinga
Can Eli Lilly Stock Double in 5 Years? Here's What It Would Take.
March 15, 2024
The company's valuation may be high but that doesn't mean Eli Lilly is anywhere near its peak.
Via
The Motley Fool
3 Weight-Loss Stocks to Buy as GLP-1 Mania Takes Hold
March 15, 2024
If you want to take advantage of the red-hot growth in weight-loss stocks, these are three companies that you can own a piece of today.
Via
InvestorPlace
Move Over, Tesla! These 6 Stocks Could Replace It in the "Magnificent 7"
March 15, 2024
Tesla is failing to keep pace with the rest of the Magnificent Seven.
Via
The Motley Fool
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
March 15, 2024
Viking Therapeutics just might be an attractive acquisition target for Pfizer.
Via
The Motley Fool
3 Pharma Stocks to Sell in March Before They Crash & Burn
March 14, 2024
Discover top pharma stocks to sell in March before they plummet. Learn why ACAD, AMLX and WST are on the list for urgent sell-off decisions.
Via
InvestorPlace
Congressional Scrutiny Intensifies On Chinese Biotech Firms: WuXi AppTec Faces Biotech Exodus
March 14, 2024
Amidst regulatory challenges, WuXi AppTec faces backlash from industry giants. Biotechnology Innovation Organization cuts ties, citing national security concerns. Shares plummet as U.S. bills target...
Via
Benzinga
7 Growth Stocks to Sell in March Before They Crash & Burn
March 14, 2024
Growth stocks are on fire to start 2024. But when the rally loses steam, these seven growth stocks to sell will come crashing down.
Via
InvestorPlace
Is WW Stock on the Brink of Bankruptcy?
March 14, 2024
It's hard to see what WW, the company formerly called Weight Watchers, can do now that Oprah Winfrey has turned against it.
Via
InvestorPlace
7 Delightful Dividend Stocks to Put Some Spring in Your Step
March 14, 2024
The best dividend stocks can be counted on to give a reliable return to income investors. These seven names are among the best to buy now.
Via
InvestorPlace
Top 7 Biotech Winners Of Novo Nordisk, Eli Lilly's Outsourcing Strategy For Weight-Loss Drugs: Goldman Sachs
March 13, 2024
Goldman Sachs analysts identified a substantial opportunity in the manufacturing sector for new obesity therapeutics, as demand for these treatments escalates.
Via
Benzinga
Eli Lilly Taps Amazon's Pharmacy To Deliver Meds, Including Weight-Loss Drug Zepbound
March 13, 2024
The company is bolstering the ways it delivers medicines through its new LillyDirect website.
Via
Investor's Business Daily
Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio
March 13, 2024
One of the primary features of Bill Gates biotech stocks is they are all working towards a cure for HIV and related illnesses.
Via
InvestorPlace
Why Is Gaxos.ai (GXAI) Stock Up 134% Today?
March 13, 2024
Gaxos.ai stock is up Wednesday with heavy trading of GXAI shares alongside it acquiring rights to new AI-enabled technology.
Via
InvestorPlace
Pharmaceutical Crime Jumps 50% As Criminals Seek To Capitalize Rising Tide of Counterfeit Weight-Loss Drugs
March 13, 2024
Combatting counterfeit weight-loss drugs: Insights into the surge, global impact, and efforts by pharmaceutical giants like Novo Nordisk and Eli Lilly to protect consumers.
Via
Benzinga
Why Is MicroCloud Hologram (HOLO) Stock Up 31% Today?
March 13, 2024
MicroCloud Hologram stock is up on Wednesday with heavy trading of HOLO shares ahead of a potential AI catalyst next week.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.